| Title : Combined vildagliptin and memantine treatment downregulates expression of amyloid precursor protein, and total and phosphorylated tau in a rat model of combined Alzheimer's disease and type 2 diabetes - Khalaf_2019_Naunyn.Schmiedebergs.Arch.Pharmacol_392_685 |
| Author(s) : Khalaf SS , Hafez MM , Mehanna ET , Mesbah NM , Abo-Elmatty DM |
| Ref : Naunyn Schmiedebergs Arch Pharmacol , 392 :685 , 2019 |
| Abstract : Khalaf_2019_Naunyn.Schmiedebergs.Arch.Pharmacol_392_685 |
| ESTHER : Khalaf_2019_Naunyn.Schmiedebergs.Arch.Pharmacol_392_685 |
| PubMedSearch : Khalaf_2019_Naunyn.Schmiedebergs.Arch.Pharmacol_392_685 |
| PubMedID: 30759264 |
Khalaf SS, Hafez MM, Mehanna ET, Mesbah NM, Abo-Elmatty DM (2019)
Combined vildagliptin and memantine treatment downregulates expression of amyloid precursor protein, and total and phosphorylated tau in a rat model of combined Alzheimer's disease and type 2 diabetes
Naunyn Schmiedebergs Arch Pharmacol
392 :685
Khalaf SS, Hafez MM, Mehanna ET, Mesbah NM, Abo-Elmatty DM (2019)
Naunyn Schmiedebergs Arch Pharmacol
392 :685